Binh Dinh Pharmaceutical and Medical Equipment 미래 성장
Future 기준 확인 0/6
Binh Dinh Pharmaceutical and Medical Equipment is forecast to grow revenue at 9.3% per annum.
주요 정보
n/a
수익 성장률
n/a
EPS 성장률
Pharmaceuticals 수익 성장 | 17.1% |
매출 성장률 | 9.3% |
향후 자기자본 수익률 | n/a |
애널리스트 커버리지 | Low |
마지막 업데이트 | 17 Sep 2024 |
최근 미래 성장 업데이트
Recent updates
수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
12/31/2025 | 1,903,000 | N/A | N/A | 306,000 | 1 |
12/31/2024 | 1,746,500 | N/A | N/A | 292,000 | 2 |
9/30/2024 | 1,694,143 | 254,652 | 161,240 | 311,385 | N/A |
6/30/2024 | 1,672,702 | 227,311 | 157,875 | 332,219 | N/A |
3/31/2024 | 1,653,745 | 230,100 | 158,431 | 330,202 | N/A |
12/31/2023 | 1,651,770 | 231,387 | 160,298 | 293,991 | N/A |
9/30/2023 | 1,672,357 | 236,045 | 120,871 | 238,422 | N/A |
6/30/2023 | 1,654,996 | 222,828 | 37,071 | 137,646 | N/A |
3/31/2023 | 1,577,853 | 226,700 | 44,624 | 116,926 | N/A |
12/31/2022 | 1,554,821 | 209,457 | 82,184 | 165,012 | N/A |
9/30/2022 | 1,494,595 | 192,082 | 133,753 | 230,426 | N/A |
6/30/2022 | 1,654,406 | 179,227 | 46,111 | 131,228 | N/A |
3/31/2022 | 1,628,301 | 175,687 | 66,423 | 145,556 | N/A |
12/31/2021 | 1,558,504 | 162,646 | 62,932 | 117,568 | N/A |
9/30/2021 | 1,500,950 | 144,547 | 96,778 | 133,723 | N/A |
6/30/2021 | 1,224,917 | 151,994 | 221,693 | 256,933 | N/A |
3/31/2021 | 1,165,758 | 136,014 | 214,423 | 261,492 | N/A |
12/31/2020 | 1,256,952 | 138,916 | 153,173 | 212,908 | N/A |
9/30/2020 | 1,310,512 | 152,680 | 61,177 | 145,361 | N/A |
6/30/2020 | 1,341,568 | 136,409 | -82,716 | 49,943 | N/A |
3/31/2020 | 1,389,839 | 134,560 | -135,292 | 15,401 | N/A |
12/31/2019 | 1,261,729 | 128,005 | -150,664 | -1,036 | N/A |
9/30/2019 | 1,251,065 | 124,796 | -80,692 | 64,892 | N/A |
6/30/2019 | 1,309,152 | 137,586 | -28,596 | 63,220 | N/A |
3/31/2019 | 1,304,700 | 140,059 | 40,962 | 104,011 | N/A |
12/31/2018 | 1,401,024 | 146,704 | 63,781 | 107,861 | N/A |
9/30/2018 | 1,400,268 | 155,163 | 144,548 | 200,583 | N/A |
6/30/2018 | 1,382,479 | 153,894 | N/A | 220,783 | N/A |
3/31/2018 | 1,393,974 | 147,133 | N/A | 95,247 | N/A |
12/31/2017 | 1,388,227 | 147,952 | N/A | 17,716 | N/A |
9/30/2017 | 1,383,637 | 144,064 | N/A | 49,414 | N/A |
6/30/2017 | 1,383,273 | 132,605 | N/A | -24,637 | N/A |
3/31/2017 | 1,380,066 | 136,230 | N/A | 22,866 | N/A |
12/31/2016 | 1,384,902 | 125,049 | N/A | 114,486 | N/A |
9/30/2016 | 1,351,117 | 95,443 | N/A | -16,678 | N/A |
6/30/2016 | 1,312,923 | 102,804 | N/A | 75,945 | N/A |
3/31/2016 | 1,297,638 | 102,753 | N/A | 296,635 | N/A |
12/31/2015 | 1,225,068 | 188,618 | N/A | 261,854 | N/A |
12/31/2014 | 1,370,460 | 48,840 | N/A | 335,369 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: Insufficient data to determine if DBD's forecast earnings growth is above the savings rate (3%).
수익 vs 시장: Insufficient data to determine if DBD's earnings are forecast to grow faster than the VN market
고성장 수익: Insufficient data to determine if DBD's earnings are expected to grow significantly over the next 3 years.
수익 대 시장: DBD's revenue (9.3% per year) is forecast to grow slower than the VN market (17.8% per year).
고성장 수익: DBD's revenue (9.3% per year) is forecast to grow slower than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if DBD's Return on Equity is forecast to be high in 3 years time